Amivantamab in Adenoid Cystic Carcinoma
Amivantamab in Adenoid Cystic Carcinoma
Active, not recruiting · NCT05074940 · Registry updated 2026-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Amivantamab in Adenoid Cystic Carcinoma | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, mouth disorder, neoplasm, salivary gland cancer, salivary gland disorder | Active, not recruiting | Phase 2 | 2026-05-08 | NCT05074940 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Trisha Wise-Draper | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Rogel Cancer Center - University of Michigan Health | Ann Arbor | United States | 1 |
| UC San Diego Moores Cancer Center | La Jolla | United States | 199 |
| University of Cincinnati Medical Center | Cincinnati | United States | 83 |
| Washington University - School of Medicine in St. Louis | St Louis | United States | 1 |